Critical analysis and report to support the widespread use of a combination therapy in Alzheimer’s disease
Analysis and report generation of widespread use of combination therapy in Europe for the treatment of Alzheimer’s disease
Summary report on EMA marketing organisation for a treatment in Alzheimer’s disease
Budget impact model in Alzheimer’s disease
Disutility study in Alzheimer’s disease
Disutility of caregiver burden associated with Alzheimer’s disease in Japan
Health state development for mild cognitive impairment in Alzheimer’s disease
Early payer value deck for Alzheimer’s disease
Targeted literature review in Alzheimer’s disease and associated insomnia
Development of additional caregiver burden items for the Resource Utilization in Dementia Questionnaire for Alzheimer’s disease
Literature research and analysis on the Alzheimer’s disease landscape in Japan
Conceptual framework for the Alzheimer’s Disease Caregiver Preference Questionnaire (ADCPQ)
Linguistic validation of the ADCPQ into Chinese
Validation of the Alzheimer’s disease caregiver preference questionnaire
Evaluation of quality of life in cognitively impaired Alzheimer’s disease patients
Review of the Alzheimer’s Disease Activity Scale-cognitive subscale (ADAS-Cog)
Development of a COA strategy for mild-moderate symptomatic Alzheimer’s disease
Development of a trial-specific caregiver satisfaction and preference questionnaire for a treatment for Alzheimer’s disease
PRO instrument development, qualification quantitative component of content validity stage and in-trial psychometric analysis stage in mild cognitive impairment
Review of the University of California San Diego Performance-based Skills Assessment (UPSA) in Alzheimer’s disease
Cognitive debriefing of the Alzheimer’s Disease Co-operative Study – Activities of Daily Living Inventory (ADCS-ADL) questionnaire
Analysis of an open label extension study in Alzheimer’s disease
Development of an online therapy tool for depression along with a landscape analysis, structured and grey literature review, local language literature review, gap analysis, local language payer interviews and clinician interviews
Literature review and advisor feedback on the burden of illness, clinical and economic outcomes in US patients receiving adjunctive treatment for major depressive disorder
Literature review of the burden of depression in haemodialysis patients (in chronic kidney disease)
Literature review and sourcing of UK unit costs in depression
KOL interviews and Delphi method to estimate the direct health care costs of treating patients with treatment-resistant depression
Delphi method to estimate healthcare resource utilisation in major depressive disorder (MDD) with suicidal ideation
Delphi study cost estimates for healthcare resource utilisation in treatment-resistant depression
Delphi panel to estimate costs associated with major depressive disorder with suicide ideation (MDSI)
Delphi panel in depression
Manuscript and content validity of a PRO measure in major depressive disorder
Validation of the Children’s Depressions Rating Scale – Revised (CDRS-R) in Japan
Translation of the CDRS-R manual
PRO dossier on major depressive disorder for EMA submission
Development of an EMA technical document for PROs in depression
Instrument review and development of an EMA technical document to support patient-reported health-related quality of life labelling claims in depression
Communications on PRO clinical trial data and a literature review on depression
Development of a manuscript and presentation based on clinical trial PRO data in depression, primarily focused on interpretation of treatment
Validation and treatment effect analysis of the Sleep Impact Scale (SIS) in major depressive disorder
Review of PRO and CRO measures in severe depression
Selection of a PRO for depression in multiple sclerosis (MS)
Linguistic validation of a quality of life questionnaire on depression into UK English
Manuscript on validation and efficacy results in depression
Linguistic validation of the Norfolk Quality of Life (QoL) questionnaire in diabetic neuropathy
Competitive analysis and burden of illness in diabetic peripheral neuropathy
Literature review of PROs and endpoints of pain in peripheral diabetic neuropathy
PRO assessment in diabetic peripheral neuropathy
Validation study of the modified version of the Brief Pain Inventory – Short Form (mBPI-SF), MOS-S and 3 single item questions in diabetic peripheral neuropathy
Gap analysis and strategic recommendation for PRO and market access studies in diabetic peripheral neuropathy
Consultancy on the validity of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale for use in painful diabetic neuropathy patients
Interview study to understand the experience of walking pain among patients with diabetic peripheral neuropathy
Mapping the health economic evidence landscape for anti-epileptic treatments
Systematic literature review and mixed treatment comparison for a treatment in epilepsy
Abstract review for the systematic literature review and mixed treatment comparison investigating treatments in epilepsy
Value dossier for an anticonvulsant medication for use in epilepsy
Evidence synthesis and modelling for an anticonvulsant medication in epilepsy
SMC submission for an anticonvulsant treatment for epilepsy
Brief literature review in epilepsy and search of FDA and EMA websites
Payer meeting and consultancy on an anti-epilepsy drug
Consultancy on an Italian model adaptation in epilepsy
Development of a US value dossier (meeting AMCP and WellPoint guidelines) and an expanded budget impact model on epilepsy
Cost-effectiveness analysis of two different anticonvulsant medications as adjunctive therapy for adults with partial refractory epilepsy in the US
Mixed treatment comparison summary for epilepsy
Dravet syndrome
Development of a composite trial endpoint for Dravet syndrome
Interviews on the development of a composite trial endpoint for Dravet syndrome
Manuscript on the development of a composite trial endpoint for Dravet syndrome
Publication support to disseminate findings from interviews with caregivers of children with Dravet syndrome, and independent qualitative analysis of findings
Lennox-Gastaut syndrome
Cost utility analysis model for Lennox-Gastaut Syndrome
Training with the client to discuss the Lennox-Gastaut Syndrome economic model/report and payer submission
Eliciting utilities in Lennox-Gastaut Syndrome
Assistance with responding to questions from the AWMSG and SMC on Lennox-Gastaut syndrome
Survey of the impact of allergy on sleep (including literature review and HCP interviews)
Value communication support for an insomnia study
Value communication support for a systematic literature review in insomnia
Global value dossier and AMCP dossier in insomnia
Systematic literature review of real world evidence in insomnia
Literature review and report update in insomnia
Advisory panel in insomnia
Targeted literature review in Alzheimer’s disease and associated insomnia
Manuscript on a publication of a systematic literature review in insomnia
Review of PROs in insomnia
Cognitive debriefing of the daytime insomnia symptom scale and FDA support
Strategic consulting in insomnia
Validation of a primary insomnia functioning questionnaire
PRO strategy in insomnia
Manuscripts on the development and validation of the Sleep Impact Scale (SIS) in insomnia
Support on translation of the SIS in insomnia
Communications on the SIS in insomnia
Support on the adaptation of the SIS into three languages
Support on linguistic validation of the SIS in insomnia
Investigator meeting, review and presentation of slides on the Functional Outcomes of Sleep Questionnaire (FOSQ) and Work Limitation Questionnaire (WLQ)
Validation of the FOSQ in insomnia
Development of a conceptual framework and endpoint model in insomnia, plus qualitative patient interviews to confirm the validity of the conceptual framework and the psychometric validation of the final conceptual framework
Consultation on study design and interpretation of data on insomnia
Advisory panel in sleep disorders
Quality of life questionnaire in sleep disorders
Modification to the Sleep Impact Questionnaire following FDA review
Validation and linguistic adaptation of a sleep questionnaire
Linguistic validation of the Fatigue Impact Scale (FIS) into Argentinean Spanish, Austrian German, South African English, Norwegian and Afrikaans
Evaluation of the potential for a satisfaction claim for sleep disorders
Development of a PRO instrument for measuring mood swings and sleep problems resulting from vasomotor symptoms during the menopause
Evaluation of existing documentation and recommendations for psychometrically validating the modified Daytime Insomnia Symptom Scale (mDISS)
Scenario model in sleep disorders
Development of a sleep measure in different conditions
Report of sleep problems in fibromyalgia
Content validation of the modified Daytime Insomnia Symptom Scale (DISS) and the Sleep Impact Questionnaire event log
Manuscript on validation and efficacy results in insomnia
Local market adaptations of economic models in anaesthesia (for neuromuscular block)
Payer value deck in neuromuscular block
Development of a conceptual framework and SAP for a treatment for neuromuscular block
Treatment effect analyses based on a Quality of Recovery questionnaire (QoR-40) and Reversal Agent Satisfaction Questionnaire (RASQ) in neuromuscular block
Core value dossier update in chronic/neuropathic pain
Update of core value dossier and value story in chronic neurological pain
Manuscript based on burden of illness study in neuropathic pain for submission to peer-reviewed journal
Rapid payer research to support investment decisions in neuropathic pain
Payer interviews in neuropathic pain
Mapping out and costing of care pathways for neuropathic pain
Use of focus groups for the assessment of PROs in neuropathic pain
Assessment of PROs in neuropathic pain
Consultation on an observational study in neuropathic pain: review of protocol and SAP to ensure that an appropriate PRO strategy can be developed for phase III studies
PRO analyses in neuropathic pain
Patient focus groups to validate a conceptual model in neuropathic pain
Translation of the Neuropathic Pain Symptom Inventory (NPSI)
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreACCEPTREJECT
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.